Ultragenyx Grants 65,886 RSUs to 39 New Non-Executive Officers

Ultragenyx Pharmaceutical Inc. reported the grant of 65,886 restricted stock units (RSUs) to 39 newly hired non-executive officers. These awards, approved by the compensation committee, were granted on July 16, 2026, under the company's Employment Inducement Plan. The RSUs are intended to induce new employees to join Ultragenyx and will vest over four years, with 25% of the shares vesting on each anniversary of the grant date, contingent on continuous employment.